|
|
Volumn 329, Issue 7470, 2004, Pages 816-
|
|
Merck withdraws arthritis drug worldwide.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
LACTONE;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
ROFECOXIB;
SULFONE;
ARTHRITIS;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMAN;
LEGAL ASPECT;
THROMBOEMBOLISM;
ARTHRITIS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
ISOENZYMES;
LACTONES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
SULFONES;
THROMBOEMBOLISM;
|
|
EID: 4944229572
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.329.7470.816-a Document Type: Article |
|
Times cited : (64)
|
|
References (0)
|
